| Year |
Citation |
Score |
| 2023 |
Pagadala M, Sears TJ, Wu VH, Pérez-Guijarro E, Kim H, Castro A, Talwar JV, Gonzalez-Colin C, Cao S, Schmiedel BJ, Goudarzi S, Kirani D, Au J, Zhang T, Landi T, ... ... Zanetti M, et al. Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response. Nature Communications. 14: 2744. PMID 37173324 DOI: 10.1038/s41467-023-38271-5 |
0.318 |
|
| 2023 |
Xian S, Dosset M, Castro A, Carter H, Zanetti M. Transcriptional analysis links B cells and TERT expression to favorable prognosis in head and neck cancer. Pnas Nexus. 2: pgad046. PMID 36909826 DOI: 10.1093/pnasnexus/pgad046 |
0.419 |
|
| 2022 |
Zanetti M, Xian S, Dosset M, Carter H. The Unfolded Protein Response at the Tumor-Immune Interface. Frontiers in Immunology. 13: 823157. PMID 35237269 DOI: 10.3389/fimmu.2022.823157 |
0.394 |
|
| 2021 |
Xian S, Dosset M, Almanza G, Searles S, Sahani P, Waller TC, Jepsen K, Carter H, Zanetti M. The unfolded protein response links tumor aneuploidy to local immune dysregulation. Embo Reports. e52509. PMID 34698427 DOI: 10.15252/embr.202152509 |
0.317 |
|
| 2021 |
Castro A, Ozturk K, Zanetti M, Carter H. In silico analysis suggests less effective MHC-II presentation of SARS-CoV-2 RBM peptides: Implication for neutralizing antibody responses. Plos One. 16: e0246731. PMID 33571241 DOI: 10.1371/journal.pone.0246731 |
0.315 |
|
| 2020 |
Castro A, Ozturk K, Zanetti M, Carter H. MHC-II constrains the natural neutralizing antibody response to the SARS-CoV-2 spike RBM in humans. Biorxiv : the Preprint Server For Biology. PMID 33398284 DOI: 10.1101/2020.12.26.424449 |
0.313 |
|
| 2020 |
Zanetti M. Ubi Maior Minor Cessat. Critical Reviews in Immunology. 40: 255-262. PMID 33389889 DOI: 10.1615/CritRevImmunol.2020034859 |
0.379 |
|
| 2020 |
Castro A, Pyke RM, Zhang X, Thompson WK, Day CP, Alexandrov LB, Zanetti M, Carter H. Strength of immune selection in tumors varies with sex and age. Nature Communications. 11: 4128. PMID 32807809 DOI: 10.1038/S41467-020-17981-0 |
0.393 |
|
| 2020 |
Dosset M, Castro A, Carter H, Zanetti M. Telomerase and CD4 T Cell Immunity in Cancer. Cancers. 12. PMID 32630460 DOI: 10.3390/Cancers12061687 |
0.533 |
|
| 2020 |
Batista A, Rodvold JJ, Xian S, Searles SC, Lew A, Iwawaki T, Almanza G, Waller TC, Lin J, Jepsen K, Carter H, Zanetti M. IRE1α regulates macrophage polarization, PD-L1 expression, and tumor survival. Plos Biology. 18: e3000687. PMID 32520957 DOI: 10.1371/Journal.Pbio.3000687 |
0.394 |
|
| 2020 |
Rodvold JJ, Xian S, Nussbacher J, Tsui B, Cameron Waller T, Searles SC, Lew A, Jiang P, Babic I, Nomura N, Lin JH, Kesari S, Carter H, Zanetti M. IRE1α and IGF signaling predict resistance to an endoplasmic reticulum stress-inducing drug in glioblastoma cells. Scientific Reports. 10: 8348. PMID 32433555 DOI: 10.1038/S41598-020-65320-6 |
0.353 |
|
| 2020 |
Searles S, Alamanza G, Zanetti M. Abstract 4067: Inhibition of XBP1 expression in murine macrophages by miR-214 delivered by extracellular vesicles Cancer Research. 80: 4067-4067. DOI: 10.1158/1538-7445.Am2020-4067 |
0.415 |
|
| 2019 |
Hiramatsu N, Chiang K, Aivati C, Rodvold JJ, Lee JM, Han J, Chea L, Zanetti M, Koo EH, Lin JH. PERK-mediated induction of microRNA-483 disrupts cellular ATP homeostasis during the unfolded protein response. The Journal of Biological Chemistry. PMID 31792031 DOI: 10.1074/Jbc.Ra119.008336 |
0.317 |
|
| 2019 |
Castro A, Ozturk K, Pyke RM, Xian S, Zanetti M, Carter H. Elevated neoantigen levels in tumors with somatic mutations in the HLA-A, HLA-B, HLA-C and B2M genes. Bmc Medical Genomics. 12: 107. PMID 31345234 DOI: 10.1186/S12920-019-0544-1 |
0.402 |
|
| 2018 |
Almanza G, Rodvold JJ, Tsui B, Jepsen K, Carter H, Zanetti M. Extracellular vesicles produced in B cells deliver tumor suppressor miR-335 to breast cancer cells disrupting oncogenic programming in vitro and in vivo. Scientific Reports. 8: 17581. PMID 30514916 DOI: 10.1038/S41598-018-35968-2 |
0.368 |
|
| 2018 |
Rodvold JJ, Zanetti M. Insidious communication amongst cancer cells. Molecular & Cellular Oncology. 5: e1356898. PMID 30250884 DOI: 10.1080/23723556.2017.1356898 |
0.412 |
|
| 2018 |
Marty R, Thompson WK, Salem RM, Zanetti M, Carter H. Evolutionary Pressure against MHC Class II Binding Cancer Mutations. Cell. PMID 30245014 DOI: 10.1016/J.Cell.2018.08.048 |
0.423 |
|
| 2018 |
Marty R, Thompson W, Ideker T, Zanetti M, Carter H. Abstract 5727: MHC II complements MHC I in shaping the mutational landscape of tumors Cancer Research. 78: 5727-5727. DOI: 10.1158/1538-7445.Am2018-5727 |
0.441 |
|
| 2017 |
Rodvold JJ, Kesari S, Zanetti M. A community affair in the tumor microenvironment. Oncotarget. 8: 106173-106174. PMID 29290938 DOI: 10.18632/Oncotarget.22586 |
0.314 |
|
| 2017 |
Kouznetsova VL, Hu H, Teigen K, Zanetti M, Tsigelny IF. Cripto stabilizes GRP78 on the cell membrane. Protein Science : a Publication of the Protein Society. PMID 29226519 DOI: 10.1002/Pro.3358 |
0.339 |
|
| 2017 |
Rodvold JJ, Chiu KT, Hiramatsu N, Nussbacher JK, Galimberti V, Mahadevan NR, Willert K, Lin JH, Zanetti M. Intercellular transmission of the unfolded protein response promotes survival and drug resistance in cancer cells. Science Signaling. 10. PMID 28588081 DOI: 10.1126/Scisignal.Aah7177 |
0.746 |
|
| 2017 |
Zanetti M. Chromosomal chaos silences immune surveillance. Science (New York, N.Y.). 355: 249-250. PMID 28104855 DOI: 10.1126/Science.Aam5331 |
0.461 |
|
| 2016 |
Rodvold JJ, Zanetti M. Tumor microenvironment on the move and the Aselli connection. Science Signaling. 9: fs13. PMID 27353363 DOI: 10.1126/Scisignal.Aag2279 |
0.426 |
|
| 2016 |
Zanetti M. A second chance for telomerase reverse transcriptase in anticancer immunotherapy. Nature Reviews. Clinical Oncology. PMID 27245281 DOI: 10.1038/Nrclinonc.2016.67 |
0.403 |
|
| 2016 |
Zanetti M, Rodvold JJ, Mahadevan NR. The evolving paradigm of cell-nonautonomous UPR-based regulation of immunity by cancer cells. Oncogene. 35: 269-78. PMID 25893303 DOI: 10.1038/Onc.2015.108 |
0.769 |
|
| 2015 |
Almanza G, Zanetti M. High-efficiency Generation of Multiple Short Noncoding RNA in B-cells and B-cell-derived Extracellular Vesicles. Molecular Therapy. Nucleic Acids. 4: e271. PMID 26670278 DOI: 10.1038/Mtna.2015.44 |
0.345 |
|
| 2015 |
Rodvold JJ, Mahadevan NR, Zanetti M. Immune modulation by ER stress and inflammation in the tumor microenvironment. Cancer Letters. PMID 26525580 DOI: 10.1016/J.Canlet.2015.09.009 |
0.772 |
|
| 2015 |
Zanetti M. Tapping CD4 T cells for cancer immunotherapy: the choice of personalized genomics. Journal of Immunology (Baltimore, Md. : 1950). 194: 2049-56. PMID 25710958 DOI: 10.4049/Jimmunol.1402669 |
0.497 |
|
| 2014 |
Del Guercio P, Zanetti M. The CD4 molecule, the human immunodeficiency virus and anti-idiotypic antibodies. Immunology Today. 8: 204-5. PMID 25290427 DOI: 10.1016/0167-5699(87)90164-2 |
0.331 |
|
| 2013 |
Almanza G, Anufreichik V, Rodvold JJ, Chiu KT, DeLaney A, Akers JC, Chen CC, Zanetti M. Synthesis and delivery of short, noncoding RNA by B lymphocytes. Proceedings of the National Academy of Sciences of the United States of America. 110: 20182-7. PMID 24277816 DOI: 10.1073/Pnas.1311145110 |
0.345 |
|
| 2013 |
Fenoglio D, Traverso P, Parodi A, Kalli F, Zanetti M, Filaci G. Generation of more effective cancer vaccines. Human Vaccines & Immunotherapeutics. 9: 2543-7. PMID 23978951 DOI: 10.4161/Hv.26147 |
0.415 |
|
| 2013 |
Mahadevan NR, Rodvold JJ, Zanetti M. A Janus-faced role of the unfolded protein response in antitumor immunity. Oncoimmunology. 2: e23901. PMID 23762789 DOI: 10.4161/Onci.23901 |
0.728 |
|
| 2013 |
Zanetti M. Cell-extrinsic effects of the tumor unfolded protein response on myeloid cells and T cells. Annals of the New York Academy of Sciences. 1284: 6-11. PMID 23651187 DOI: 10.1111/Nyas.12103 |
0.499 |
|
| 2013 |
Mahadevan NR, Zanetti M. Sensing hyperploidy and immune surveillance: a pas-de-deux. Cell Cycle (Georgetown, Tex.). 12: 544-5. PMID 23370385 DOI: 10.4161/Cc.23678 |
0.787 |
|
| 2013 |
Kumandan S, Mahadevan NR, Chiu K, DeLaney A, Zanetti M. Activation of the unfolded protein response bypasses trastuzumab-mediated inhibition of the PI-3K pathway. Cancer Letters. 329: 236-42. PMID 23200669 DOI: 10.1016/J.Canlet.2012.11.014 |
0.698 |
|
| 2013 |
Rodvold JJ, Hiramatsu N, Chiu KT, Mahadevan NR, Lin J, Zanetti M. Abstract B51: Tumor ER stress transmission to infiltrating myeloid cells in vivo require IRE1alpha and TLR4 Cancer Research. 73. DOI: 10.1158/1538-7445.Fbcr13-B51 |
0.759 |
|
| 2012 |
Mahadevan NR, Anufreichik V, Rodvold JJ, Chiu KT, Sepulveda H, Zanetti M. Cell-Extrinsic Effects of Tumor ER Stress Imprint Myeloid Dendritic Cells and Impair CD8+ T Cell Priming Plos One. 7. PMID 23272178 DOI: 10.1371/Journal.Pone.0051845 |
0.771 |
|
| 2012 |
Zanetti M, Mahadevan NR. Cancer. Immune surveillance from chromosomal chaos? Science (New York, N.Y.). 337: 1616-7. PMID 23019639 DOI: 10.1126/Science.1228464 |
0.741 |
|
| 2012 |
Rodvold JJ, Mahadevan NR, Zanetti M. Lipocalin 2 in cancer: when good immunity goes bad. Cancer Letters. 316: 132-8. PMID 22075378 DOI: 10.1016/J.Canlet.2011.11.002 |
0.731 |
|
| 2012 |
Kumandan S, Mahadevan NR, DeLaney A, Zanetti M. Abstract A5: Can activation of the UPR lead to Trastuzumab resistance? Clinical Cancer Research. 18: A5-A5. DOI: 10.1158/1078-0432.Mechres-A5 |
0.699 |
|
| 2011 |
Mahadevan NR, Zanetti M. Tumor stress inside out: cell-extrinsic effects of the unfolded protein response in tumor cells modulate the immunological landscape of the tumor microenvironment. Journal of Immunology (Baltimore, Md. : 1950). 187: 4403-9. PMID 22013206 DOI: 10.4049/Jimmunol.1101531 |
0.753 |
|
| 2011 |
Mahadevan NR, Rodvold J, Almanza G, Pérez AF, Wheeler MC, Zanetti M. ER stress drives Lipocalin 2 upregulation in prostate cancer cells in an NF-κB-dependent manner. Bmc Cancer. 11: 229. PMID 21649922 DOI: 10.1186/1471-2407-11-229 |
0.717 |
|
| 2011 |
Mahadevan NR, Rodvold J, Sepulveda H, Rossi S, Drew AF, Zanetti M. Transmission of endoplasmic reticulum stress and pro-inflammation from tumor cells to myeloid cells Proceedings of the National Academy of Sciences of the United States of America. 108: 6561-6566. PMID 21464300 DOI: 10.1073/Pnas.1008942108 |
0.725 |
|
| 2010 |
Mahadevan NR, Fernandez A, Rodvold JJ, Almanza G, Zanetti M. Prostate cancer cells undergoing ER stress in vitro and in vivo activate transcription of pro-inflammatory cytokines. Journal of Inflammation Research. 3: 99-103. PMID 22096360 DOI: 10.2147/Jir.S11190 |
0.723 |
|
| 2010 |
Franco A, Almanza G, Burns JC, Wheeler M, Zanetti M. Endoplasmic reticulum stress drives a regulatory phenotype in human T-cell clones. Cellular Immunology. 266: 1-6. PMID 20951371 DOI: 10.1016/J.Cellimm.2010.09.006 |
0.405 |
|
| 2010 |
Zanetti M, Castiglioni P, Ingulli E. Principles of memory CD8 T-cells generation in relation to protective immunity. Advances in Experimental Medicine and Biology. 684: 108-25. PMID 20795544 DOI: 10.1007/978-1-4419-6451-9_9 |
0.405 |
|
| 2010 |
Cortez-Gonzalez X, Zanetti M. Identification of immunogenic peptides of the self-tumor antigen: our experience with telomerase reverse transcriptase. Methods in Molecular Biology (Clifton, N.J.). 651: 211-25. PMID 20686968 DOI: 10.1007/978-1-60761-786-0_12 |
0.781 |
|
| 2010 |
Almanza G, Fernandez A, Volinia S, Cortez-Gonzalez X, Croce CM, Zanetti M. Selected microRNAs define cell fate determination of murine central memory CD8 T cells. Plos One. 5: e11243. PMID 20582165 DOI: 10.1371/Journal.Pone.0011243 |
0.774 |
|
| 2009 |
Ingulli E, Funatake C, Jacovetty EL, Zanetti M. Cutting edge: antigen presentation to CD8 T cells after influenza A virus infection. Journal of Immunology (Baltimore, Md. : 1950). 182: 29-33. PMID 19109130 DOI: 10.4049/Jimmunol.182.1.29 |
0.364 |
|
| 2008 |
Pellicciotta I, Cortez-Gonzalez X, Sasik R, Reiter Y, Hardiman G, Langlade-Demoyen P, Zanetti M. Presentation of telomerase reverse transcriptase, a self-tumor antigen, is down-regulated by histone deacetylase inhibition. Cancer Research. 68: 8085-93. PMID 18829567 DOI: 10.1158/0008-5472.Can-08-1014 |
0.804 |
|
| 2008 |
Vaccari M, Mattapallil J, Song K, Tsai WP, Hryniewicz A, Venzon D, Zanetti M, Reimann KA, Roederer M, Franchini G. Reduced protection from simian immunodeficiency virus SIVmac251 infection afforded by memory CD8+ T cells induced by vaccination during CD4+ T-cell deficiency. Journal of Virology. 82: 9629-38. PMID 18667509 DOI: 10.1128/Jvi.00893-08 |
0.422 |
|
| 2008 |
Wheeler MC, Rizzi M, Sasik R, Almanza G, Hardiman G, Zanetti M. KDEL-retained antigen in B lymphocytes induces a proinflammatory response: a possible role for endoplasmic reticulum stress in adaptive T cell immunity. Journal of Immunology (Baltimore, Md. : 1950). 181: 256-64. PMID 18566391 DOI: 10.4049/Jimmunol.181.1.256 |
0.492 |
|
| 2008 |
Castiglioni P, Hall de S, Jacovetty EL, Ingulli E, Zanetti M. Protection against influenza A virus by memory CD8 T cells requires reactivation by bone marrow-derived dendritic cells. Journal of Immunology (Baltimore, Md. : 1950). 180: 4956-64. PMID 18354221 DOI: 10.4049/Jimmunol.180.7.4956 |
0.409 |
|
| 2008 |
Chen SS, Barankiewicz T, Yang YM, Zanetti M, Hill P. Protection of IgE-mediated allergic sensitization by active immunization with IgE loops constrained in GFP protein scaffold. Journal of Immunological Methods. 333: 10-23. PMID 18281056 DOI: 10.1016/J.Jim.2007.10.007 |
0.354 |
|
| 2007 |
Zanetti M. Immunity and protection, the unfolding of a tale. Immunologic Research. 38: 305-18. PMID 17917038 DOI: 10.1007/S12026-007-0005-3 |
0.461 |
|
| 2007 |
Frazzi R, Zanetti M. Plasmid DNA and IL-4 modulate expression of mHC class I and costimulatory molecules in B lymphocytes. Dna and Cell Biology. 26: 148-59. PMID 17417943 DOI: 10.1089/Dna.2006.0539 |
0.39 |
|
| 2007 |
Cortez-Gonzalez X, Zanetti M. Telomerase immunity from bench to bedside: round one. Journal of Translational Medicine. 5: 12. PMID 17324292 DOI: 10.1186/1479-5876-5-12 |
0.807 |
|
| 2007 |
Zanetti M. Gating on germinal center B cells Blood. 110: 3816-3817. DOI: 10.1182/Blood-2007-08-105502 |
0.372 |
|
| 2006 |
Cortez-Gonzalez X, Sidney J, Adotevi O, Sette A, Millard F, Lemonnier F, Langlade-Demoyen P, Zanetti M. Immunogenic HLA-B7-restricted peptides of hTRT. International Immunology. 18: 1707-18. PMID 17077179 DOI: 10.1093/Intimm/Dxl105 |
0.773 |
|
| 2006 |
Zanetti M, Franchini G. T cell memory and protective immunity by vaccination: is more better? Trends in Immunology. 27: 511-7. PMID 16997631 DOI: 10.1016/J.It.2006.09.004 |
0.443 |
|
| 2006 |
Koch KS, Son KH, Maehr R, Pellicciotta I, Ploegh HL, Zanetti M, Sell S, Leffert HL. Immune-privileged embryonic Swiss mouse STO and STO cell-derived progenitor cells: Major histocompatibility complex and cell differentiation antigen expression patterns resemble those of human embryonic stem cell lines Immunology. 119: 98-115. PMID 16836618 DOI: 10.1111/J.1365-2567.2006.02412.X |
0.404 |
|
| 2006 |
Wheeler M, Cortez-Gonzalez X, Frazzi R, Zanetti M. Ex vivo programming of antigen-presenting B lymphocytes: considerations on DNA uptake and cell activation. International Reviews of Immunology. 25: 83-97. PMID 16818366 DOI: 10.1080/08830180600743131 |
0.78 |
|
| 2006 |
Cortez-Gonzalez X, Pellicciotta I, Gerloni M, Wheeler MC, Castiglioni P, Lenert P, Zanetti M. TLR9-independent activation of B lymphocytes by bacterial DNA. Dna and Cell Biology. 25: 253-61. PMID 16716115 DOI: 10.1089/Dna.2006.25.253 |
0.778 |
|
| 2006 |
Adotévi O, Mollier K, Neuveut C, Cardinaud S, Boulanger E, Mignen B, Fridman WH, Zanetti M, Charneau P, Tartour E, Lemonnier F, Langlade-Demoyen P. Immunogenic HLA-B*0702-restricted epitopes derived from human telomerase reverse transcriptase that elicit antitumor cytotoxic T-cell responses. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 3158-67. PMID 16707616 DOI: 10.1158/1078-0432.Ccr-05-2647 |
0.475 |
|
| 2006 |
Filaci G, Fravega M, Setti M, Traverso P, Millo E, Fenoglio D, Negrini S, Ferrera F, Romagnoli A, Basso M, Contini P, Rizzi M, Ghio M, Benatti U, Damonte G, ... ... Zanetti M, et al. Frequency of telomerase-specific CD8+ T lymphocytes in patients with cancer. Blood. 107: 1505-12. PMID 16249379 DOI: 10.1182/Blood-2005-01-0258 |
0.463 |
|
| 2006 |
Filaci G, Fravega M, Setti M, Traverso P, Millo E, Fenoglio D, Negrini S, Ferrera F, Romagnoli A, Basso M, Contini P, Rizzi M, Ghio M, Benatti U, Damonte G, ... ... Zanetti M, et al. F.123. Frequency of Telomerase-Specific CD8+ T Lymphocytes in Cancer Patients Clinical Immunology. 119: S94. DOI: 10.1016/J.Clim.2006.04.163 |
0.349 |
|
| 2005 |
Gerloni M, Castiglioni P, Zanetti M. The cooperation between two CD4 T cells induces tumor protective immunity in MUC.1 transgenic mice. Journal of Immunology (Baltimore, Md. : 1950). 175: 6551-9. PMID 16272309 DOI: 10.4049/Jimmunol.175.10.6551 |
0.524 |
|
| 2005 |
Zanetti M. T for two: when helpers need help. Autoimmunity Reviews. 4: 571-8. PMID 16214098 DOI: 10.1016/J.Autrev.2005.04.001 |
0.439 |
|
| 2005 |
Vaccari M, Trindade CJ, Venzon D, Zanetti M, Franchini G. Vaccine-induced CD8+ central memory T cells in protection from simian AIDS. Journal of Immunology (Baltimore, Md. : 1950). 175: 3502-7. PMID 16148092 DOI: 10.4049/Jimmunol.175.6.3502 |
0.4 |
|
| 2005 |
Rizzi M, Gerloni M, Srivastava AS, Wheeler MC, Schuler K, Carrier E, Zanetti M. In utero DNA immunisation. Immunity over tolerance in fetal life. Vaccine. 23: 4273-82. PMID 16005117 DOI: 10.1016/J.Vaccine.2004.11.046 |
0.438 |
|
| 2005 |
Gerloni M, Zanetti M. CD4 T cells in tumor immunity. Springer Seminars in Immunopathology. 27: 37-48. PMID 15965712 DOI: 10.1007/S00281-004-0193-Z |
0.53 |
|
| 2005 |
Chen SS, Gong J, Yang YM, Oettgen H, Zanetti M. Cytotoxic T-cells specific for natural IgE peptides downregulate IgE production. Cellular Immunology. 233: 11-22. PMID 15913585 DOI: 10.1016/J.Cellimm.2005.02.005 |
0.405 |
|
| 2005 |
Castiglioni P, Gerloni M, Cortez-Gonzalez X, Zanetti M. CD8 T cell priming by B lymphocytes is CD4 help dependent. European Journal of Immunology. 35: 1360-70. PMID 15816014 DOI: 10.1002/Eji.200425530 |
0.783 |
|
| 2005 |
Zanetti M, Hernandez X, Langlade-Demoyen P. Telomerase reverse transcriptase as target for anti-tumor T cell responses in humans. Springer Seminars in Immunopathology. 27: 87-104. PMID 15711953 DOI: 10.1007/S00281-004-0197-8 |
0.53 |
|
| 2005 |
Gerloni M, Wheeler M, Cortez-Gonzales X, Pellicciotta I, Zanetti M. 179. Transgenesis of B Lymphocytes by Bacterial DNA Is TLR9 Independent Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.182 |
0.425 |
|
| 2004 |
Castiglioni P, Gerloni M, Zanetti M. Genetically programmed B lymphocytes are highly efficient in inducing anti-virus protective immunity mediated by central memory CD8 T cells. Vaccine. 23: 699-708. PMID 15542193 DOI: 10.1016/J.Vaccine.2004.06.028 |
0.427 |
|
| 2004 |
Musselli C, Daverio-Zanetti S, Zanetti M. Antigenized antibodies expressing Vbeta8.2 TCR peptides immunize against rat experimental allergic encephalomyelitis. Journal of Immune Based Therapies and Vaccines. 2: 9. PMID 15541175 DOI: 10.1186/1476-8518-2-9 |
0.455 |
|
| 2004 |
Hernández J, Schoeder K, Blondelle SE, Pons FG, Lone YC, Simora A, Langlade-Demoyen P, Wilson DB, Zanetti M. Antigenicity and immunogenicity of peptide analogues of a low affinity peptide of the human telomerase reverse transcriptase tumor antigen. European Journal of Immunology. 34: 2331-41. PMID 15259031 DOI: 10.1002/Eji.200425134 |
0.374 |
|
| 2004 |
Zanetti M, Castiglioni P, Rizzi M, Wheeler M, Gerloni M. B lymphocytes as antigen-presenting cell-based genetic vaccines. Immunological Reviews. 199: 264-78. PMID 15233740 DOI: 10.1111/J.0105-2896.2004.00152.X |
0.461 |
|
| 2004 |
Gerloni M, Rizzi M, Castiglioni P, Zanetti M. T cell immunity using transgenic B lymphocytes. Proceedings of the National Academy of Sciences of the United States of America. 101: 3892-7. PMID 15004284 DOI: 10.1073/Pnas.0400138101 |
0.53 |
|
| 2004 |
Filaci G, Gerloni M, Rizzi M, Castiglioni P, Chang HD, Wheeler MC, Fiocca R, Zanetti M. Spontaneous transgenesis of human B lymphocytes. Gene Therapy. 11: 42-51. PMID 14681696 DOI: 10.1038/SJ.GT.3302132 |
0.331 |
|
| 2004 |
Gerloni M, Rizzi M, Castiglioni P, Wheeler M, Zanetti M. 1043. Spontaneous Transfection of B Lymphocytes Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.988 |
0.384 |
|
| 2004 |
Gerloni M, Rizzi M, Castiglioni P, Zanetti M. 564. T Cell Immunity Using Transgenic B Lymphocytes Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.488 |
0.518 |
|
| 2003 |
Zanetti M, Castiglioni P, Schoenberger S, Gerloni M. The role of relB in regulating the adaptive immune response. Annals of the New York Academy of Sciences. 987: 249-57. PMID 12727647 DOI: 10.1111/J.1749-6632.2003.Tb06056.X |
0.427 |
|
| 2003 |
Langlade-Demoyen P, Garcia-Pons F, Castiglioni P, Garcia Z, Cardinaud S, Xiong S, Gerloni M, Zanetti M. Role of T cell help and endoplasmic reticulum targeting in protective CTL response against influenza virus. European Journal of Immunology. 33: 720-8. PMID 12616492 DOI: 10.1002/Eji.200323287 |
0.47 |
|
| 2003 |
Moss RB, Brandt C, Giermakowska WK, Savary JR, Theofan G, Zanetti M, Carlo DJ, Wallace MR. HIV-specific immunity during structured antiviral drug treatment interruption. Vaccine. 21: 1066-71. PMID 12559781 DOI: 10.1016/S0264-410X(02)00610-2 |
0.304 |
|
| 2003 |
Filaci G, Contini P, Fravega M, Fenoglio D, Azzarone B, Julien-Giron M, Fiocca R, Boggio M, Necchi V, De Lerma Barbaro A, Merlo A, Rizzi M, Ghio M, Setti M, Puppo F, ... Zanetti M, et al. Apoptotic DNA binds to HLA class II molecules inhibiting antigen presentation and participating in the development of anti-inflammatory functional behavior of phagocytic macrophages. Human Immunology. 64: 9-20. PMID 12507810 DOI: 10.1016/S0198-8859(02)00778-4 |
0.44 |
|
| 2003 |
Castiglioni P, Lu C, Lo D, Croft M, Langlade-Demoyen P, Zanetti M, Gerloni M. CD4 T cell priming in dendritic cell-deficient mice. International Immunology. 15: 127-36. PMID 12502733 DOI: 10.1093/Intimm/Dxg015 |
0.479 |
|
| 2002 |
Hernandez J, Garcia-Pons F, Lone YC, Firat H, Schmidt JD, Langlade-Demoyen P, Zanetti M. Identification of a human telomerase reverse transcriptase peptide of low affinity for HLA A2.1 that induces cytotoxic T lymphocytes and mediates lysis of tumor cells. Proceedings of the National Academy of Sciences of the United States of America. 99: 12275-80. PMID 12218171 DOI: 10.1073/Pnas.182418399 |
0.476 |
|
| 2002 |
Castiglioni P, Janssen EM, Prilliman KR, Gerloni M, Schoenberger S, Zanetti M. Cross-priming is under control of the relB gene. Scandinavian Journal of Immunology. 56: 219-23. PMID 12193222 DOI: 10.1046/J.1365-3083.2002.01144.X |
0.423 |
|
| 2002 |
Gerloni M, Zanetti M. Studies on CD4 T cell immunity using somatic transgene immunization. International Reviews of Immunology. 20: 613-25. PMID 11890615 DOI: 10.3109/08830180109045581 |
0.496 |
|
| 2002 |
Schuler K, Lu C, Chang HD, Croft M, Zanetti M, Gerloni M. Circumvention of MHC class II restriction by genetic immunization. Vaccine. 20: 630-4. PMID 11672931 DOI: 10.1016/S0264-410X(01)00338-3 |
0.441 |
|
| 2001 |
Gerloni M, Xiong S, Mukerjee S, Schoenberger SP, Croft M, Zanetti M. Functional cooperation between T helper cell determinants. Proceedings of the National Academy of Sciences of the United States of America. 97: 13269-74. PMID 11069291 DOI: 10.1073/Pnas.230429197 |
0.494 |
|
| 2000 |
Minev B, Hipp J, Firat H, Schmidt JD, Langlade-Demoyen P, Zanetti M. Cytotoxic T cell immunity against telomerase reverse transcriptase in humans. Proceedings of the National Academy of Sciences of the United States of America. 97: 4796-801. PMID 10759561 DOI: 10.1073/Pnas.070560797 |
0.5 |
|
| 1999 |
Filaci G, Bacchetta R, Zanetti M. Is there a role for NK cells in the pathogenesis of multiple sclerosis? A case study. Human Immunology. 60: 231-8. PMID 10321959 DOI: 10.1016/S0198-8859(98)00121-9 |
0.383 |
|
| 1998 |
Gerloni M, Lo D, Ballou WR, Zanetti M. Immunological memory after somatic transgene immunization is positively affected by priming with GM-CSF and does not require bone marrow-derived dendritic cells. European Journal of Immunology. 28: 1832-8. PMID 9645364 DOI: 10.1002/(Sici)1521-4141(199806)28:06<1832::Aid-Immu1832>3.0.Co;2-J |
0.442 |
|
| 1998 |
Gerloni M, Xiong S, Zanetti M. Durable immunity and immunologic memory to a parasite antigen induced by somatic transgene immunization. Vaccine. 16: 293-297. PMID 9607045 DOI: 10.1016/S0264-410X(97)00167-9 |
0.419 |
|
| 1998 |
Gerloni M, Lo D, Zanetti M. DNA immunization in relB-deficient mice discloses a role for dendritic cells in IgM-->IgG1 switch in vivo. European Journal of Immunology. 28: 516-24. PMID 9521061 DOI: 10.1002/(Sici)1521-4141(199802)28:02<516::Aid-Immu516>3.0.Co;2-M |
0.405 |
|
| 1997 |
Xiong S, Gerloni M, Zanetti M. Engineering vaccines with heterologous B and T cell epitopes using immunoglobulin genes. Nature Biotechnology. 15: 882-6. PMID 9306404 DOI: 10.1038/Nbt0997-882 |
0.42 |
|
| 1997 |
Gerloni M, Baliou WR, Billetta R, Zanetti M. Immunity to Plasmodium falciparum malaria sporozoites by somatic transgene immunization. Nature Biotechnology. 15: 876-81. PMID 9306403 DOI: 10.1038/Nbt0997-876 |
0.426 |
|
| 1997 |
Lanza P, Felding-Habermann B, Ruggeri ZM, Zanetti M, Billetta R. Selective interaction of a conformationally-constrained Arg-Gly-Asp (RGD) motif with the integrin receptor alphavbeta3 expressed on human tumor cells. Blood Cells, Molecules & Diseases. 23: 230-41. PMID 9268674 DOI: 10.1006/Bcmd.1997.0140 |
0.425 |
|
| 1997 |
Xiong S, Gerloni M, Zanetti M. In vivo role of B lymphocytes in somatic transgene immunization Proceedings of the National Academy of Sciences of the United States of America. 94: 6352-6357. PMID 9177221 DOI: 10.1073/Pnas.94.12.6352 |
0.41 |
|
| 1995 |
Lenert P, Lenert G, Zanetti M. Human recombinant CD4 and CD4-derived synthetic peptides agglutinate immunoglobulin-coated latex particles. Evidence that residues 25–28 and 35–38 of human CD4 form two separate immunoglobulin binding sites Molecular Immunology. 32: 1399-1404. PMID 8643109 DOI: 10.1016/0161-5890(95)00096-8 |
0.326 |
|
| 1995 |
Rossi F, Billetta R, Ruggeri Z, Zanetti M. Engineered idiotypes. Immunochemical analysis of antigenized antibodies expressing a conformationally constrained Arg-Gly-Asp motif Molecular Immunology. 32: 341-346. PMID 7739571 DOI: 10.1016/0161-5890(94)00163-U |
0.311 |
|
| 1995 |
Billetta R, Filaci G, Zanetti M. Major histocompatibility complex class I-restricted presentation of influenza virus nucleoprotein peptide by B lymphoma cells harboring an antibody gene antigenized with the virus peptide. European Journal of Immunology. 25: 776-83. PMID 7705408 DOI: 10.1002/Eji.1830250323 |
0.395 |
|
| 1994 |
Mehta RL, Lenert P, Zanetti M. Synthetic Peptides Of Human Cd4 Enhance Binding Of Immunoglobulins To Monocyte/Macrophage Cells. Ii: Mechanisms Of Enhancement Cellular Immunology. 156: 146-154. PMID 8200032 DOI: 10.1006/Cimm.1994.1160 |
0.373 |
|
| 1994 |
Antonenko S, Zanetti M. Production and characterization of cross-reactive monoclonal antibodies to sweet proteins Life Sciences. 55: 1187-1192. PMID 7934615 DOI: 10.1016/0024-3205(94)00657-1 |
0.323 |
|
| 1994 |
Rigaudy P, Simon S, Hunter T, Sollazzo M, Billetta R, Zanetti M, Eckhart W. Antibodies specific for the neuronal form of the Src protein elicited by an antigenized antibody. Dna and Cell Biology. 13: 585-91. PMID 7517679 DOI: 10.1089/Dna.1994.13.585 |
0.314 |
|
| 1993 |
Lanza P, Billetta R, Antonenko S, Zanetti M. Active immunity against the CD4 receptor by using an antibody antigenized with residues 41-55 of the first extracellular domain. Proceedings of the National Academy of Sciences of the United States of America. 90: 11683-11687. PMID 8265609 DOI: 10.1073/Pnas.90.24.11683 |
0.39 |
|
| 1993 |
Billetta R, Zanetti M. Antigenicity and immunogenicity of antigenized antibodies. Studies on B and T cells. International Reviews of Immunology. 10: 251-263. PMID 7689625 DOI: 10.3109/08830189309061700 |
0.386 |
|
| 1993 |
Zanetti M, Lenert G, Springer GF. Idiotypes of pre-existing human anti-carcinoma anti-T and anti-Tn antibodies. International Immunology. 5: 113-9. PMID 7680895 DOI: 10.1093/Intimm/5.2.113 |
0.321 |
|
| 1993 |
Zanetti M, Filaci G, Lee R, del Guercio P, Rossi F, Bacchetta R, Stevenson F, Barnaba V, Billetta R. Expression of conformationally constrained adhesion peptide in an antibody CDR loop and inhibition of natural killer cell cytotoxic activity by an antibody antigenized with the RGD motif. The Embo Journal. 12: 4375-4384. DOI: 10.1002/J.1460-2075.1993.Tb06122.X |
0.419 |
|
| 1992 |
Zanetti M, Rogers J, Katz DH. Perturbation of the autoimmune network. I. Immunization with anti-idiotypic antibodies prior to challenge with antigen induces quantitative variations in the autoantibody response. Autoimmunity. 1: 23-36. PMID 2979602 DOI: 10.3109/08916938808997173 |
0.348 |
|
| 1992 |
Zanetti M. Ontogeny of the immune system and the invisible frontier to immune regulation. International Reviews of Immunology. 8: 209-18. PMID 1602213 DOI: 10.3109/08830189209055574 |
0.451 |
|
| 1992 |
Lanza P, Washington LC, Zanetti M. A method to analyze the interaction between gp120 of human immunodeficiency virus and CD4 Viral Immunology. 5: 305-310. PMID 1472279 DOI: 10.1089/Vim.1992.5.305 |
0.317 |
|
| 1992 |
Billetta R, Zanetti M. Ligand expression using antigenization of antibody: Principle and methods Immunomethods. 1: 41-51. DOI: 10.1016/S1058-6687(05)80027-0 |
0.309 |
|
| 1991 |
Molinaro GA, Glotz D, Zanetti M. Early ontogeny of rheumatoid factor antibodies. Characterization of a murine neonatal hybridoma autoantibody to IgGl in BALB/c mice. Autoimmunity. 4: 9-19. PMID 2485084 DOI: 10.3109/08916938909034355 |
0.304 |
|
| 1991 |
Billetta R, Hollingdale MR, Zanetti M. Immunogenicity of an engineered internal image antibody Proceedings of the National Academy of Sciences of the United States of America. 88: 4713-4717. PMID 1905014 DOI: 10.1073/Pnas.88.11.4713 |
0.354 |
|
| 1991 |
Lenert P, Zanetti M. CD4/immunoglobulin interaction: implications for immune physiology and autoimmunity International Reviews of Immunology. 7: 237-244. PMID 1757749 DOI: 10.3109/08830189109061777 |
0.397 |
|
| 1991 |
Hildebrandt S, Weiner ES, Earnshaw WC, Zanetti M, Rothfield NF. Idiotypic analysis of human anticentromere autoantibodies. Autoimmunity. 9: 131-40. PMID 1657226 DOI: 10.3109/08916939109006749 |
0.342 |
|
| 1990 |
Lenert P, Kroon D, Spiegelberg H, Golub ES, Zanetti M. Human CD4 binds immunoglobulins. Science (New York, N.Y.). 248: 1639-43. PMID 2363051 DOI: 10.1126/Science.2363051 |
0.33 |
|
| 1990 |
Sollazzo M, Castiglia D, Billetta R, Tramontano A, Zanetti M. Structural definition by antibody engineering of an idiotypic determinant Protein Engineering. 3: 531-539. PMID 2115164 DOI: 10.1093/Protein/3.6.531 |
0.368 |
|
| 1990 |
sollazzo M, Billetta R, Zanetti M. Expression of an exogenous peptide epitope genetically engineered in the variable domain of an immunoglobulin: implications for antibody and peptide folding Protein Engineering. 4: 215-220. PMID 1706095 DOI: 10.1093/Protein/4.2.215 |
0.31 |
|
| 1989 |
Zanetti M. Anti-Idiotypic Immunity: Considerations on the Immunology of Kidney Diseases1 Contributions to Nephrology. 69: 9-17. DOI: 10.1159/000416740 |
0.334 |
|
| 1988 |
Zanetti M, Glotz D, Sollazzo M. Idiotype regulation of self responses, autoantibody V regions and neonatal B cell repertoire. Immunology Letters. 16: 277-82. PMID 3502121 DOI: 10.1016/0165-2478(87)90158-1 |
0.413 |
|
| 1986 |
Del Guercio P, Del Guercio MF, Zanetti M, Katz DH. B-lymphocyte regulation of the immune system. III. Preparation and characterization of rabbit antibodies that inhibit the biological activity of the lymphokine, B-cell-derived enhancing factor (BEF). Cellular Immunology. 98: 333-40. PMID 3489549 DOI: 10.1016/0008-8749(86)90293-5 |
0.405 |
|
| 1984 |
Zanetti M, Altman A, Evans K, Rogers J. Autoreactive rat T-cell lines: establishment and cellular characteristics. Cellular Immunology. 84: 341-351. PMID 6231111 DOI: 10.1016/0008-8749(84)90106-0 |
0.385 |
|
| 1983 |
Zanetti M. Anti-Idiotypic Antibodies and Autoantibodies Annals of the New York Academy of Sciences. 418: 363-378. PMID 6608905 DOI: 10.1111/J.1749-6632.1983.Tb18086.X |
0.33 |
|
| Show low-probability matches. |